[HTML][HTML] Circulating angiogenic factors and the risk of preeclampsia
RJ Levine, SE Maynard, C Qian, KH Lim… - New England journal …, 2004 - Mass Medical Soc
Background The cause of preeclampsia remains unclear. Limited data suggest that excess
circulating soluble fms-like tyrosine kinase 1 (sFlt-1), which binds placental growth factor …
circulating soluble fms-like tyrosine kinase 1 (sFlt-1), which binds placental growth factor …
Circulating angiogenic factors and the risk of preeclampsia
RJ Levine, SE Maynard, C Qian… - The New England …, 2004 - pubmed.ncbi.nlm.nih.gov
Background The cause of preeclampsia remains unclear. Limited data suggest that excess
circulating soluble fms-like tyrosine kinase 1 (sFlt-1), which binds placental growth factor …
circulating soluble fms-like tyrosine kinase 1 (sFlt-1), which binds placental growth factor …
[引用][C] Circulating angiogenic factors and the risk of preeclampsia
RJ LEVINE, SE MAYNARD, BM SIBAI… - The New England …, 2004 - pascal-francis.inist.fr
Circulating angiogenic factors and the risk of preeclampsia CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Circulating Angiogenic Factors and the Risk of Preeclampsia
RJ Levine, SE Maynard, C Qian, KH Lim - New England Journal of …, 2004 - elibrary.ru
Before the onset of preeclampsia, there were particularly large differences between the
concentrations of sFlt-1 and PlGF in controls and those in women who later had early-onset …
concentrations of sFlt-1 and PlGF in controls and those in women who later had early-onset …
Circulating Angiogenic Factors and the Risk of Preeclampsia
RJ Levine, SE Maynard, C Qian… - … England Journal of …, 2004 - pure.johnshopkins.edu
BACKGROUND: The cause of preeclampsia remains unclear. Limited data suggest that
excess circulating soluble fms-like tyrosine kinase 1 (sFlt-1), which binds placental growth …
excess circulating soluble fms-like tyrosine kinase 1 (sFlt-1), which binds placental growth …
[PDF][PDF] Circulating Angiogenic Factors and the Risk of Preeclampsia
RJ Levine, SE Maynard, C Qian, KH Lim… - N Engl J …, 2004 - courses.fetalmedicine.com
We performed a nested case–control study within the Calcium for Preeclampsia Prevention
trial, which involved healthy nulliparous women. Each woman with preeclampsia was …
trial, which involved healthy nulliparous women. Each woman with preeclampsia was …
Circulating angiogenic factors and the risk of preeclampsia.
RJ Levine, SE Maynard, C Qian, KH Lim… - The New England …, 2004 - europepmc.org
Background The cause of preeclampsia remains unclear. Limited data suggest that excess
circulating soluble fms-like tyrosine kinase 1 (sFlt-1), which binds placental growth factor …
circulating soluble fms-like tyrosine kinase 1 (sFlt-1), which binds placental growth factor …
[PDF][PDF] Circulating Angiogenic Factors and the Risk of Preeclampsia
RJ Levine, SE Maynard, C Qian, KH Lim, LJ England… - N Engl J Med, 2004 - academia.edu
We performed a nested case–control study within the Calcium for Preeclampsia Prevention
trial, which involved healthy nulliparous women. Each woman with preeclampsia was …
trial, which involved healthy nulliparous women. Each woman with preeclampsia was …
Circulating angiogenic factors and the risk of preeclampsia.
RJ Levine, SE Maynard, C Qian, KH Lim, LJ England… - 2004 - cabidigitallibrary.org
Objective: To describe the gestational patterns of circulating soluble fms-like tyrosine kinase
1 (sFlt-1), free placental growth factor (PlGF) and free vascular endothelial growth factor …
1 (sFlt-1), free placental growth factor (PlGF) and free vascular endothelial growth factor …
[PDF][PDF] Circulating Angiogenic Factors and the Risk of Preeclampsia
RJ Levine, SE Maynard, C Qian, KH Lim… - N Engl J …, 2004 - researchgate.net
We performed a nested case–control study within the Calcium for Preeclampsia Prevention
trial, which involved healthy nulliparous women. Each woman with preeclampsia was …
trial, which involved healthy nulliparous women. Each woman with preeclampsia was …